ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 166 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.08 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $226,489 | +1158.3% | 10,868 | +2902.2% | 0.02% | +1400.0% |
| Q2 2020 | $18,000 | -52.6% | 362 | -59.0% | 0.00% | 0.0% |
| Q4 2019 | $38,000 | +5.6% | 884 | -34.8% | 0.00% | -50.0% |
| Q2 2019 | $36,000 | -30.8% | 1,355 | -30.1% | 0.00% | -33.3% |
| Q1 2019 | $52,000 | -93.3% | 1,939 | -96.2% | 0.00% | -93.9% |
| Q2 2018 | $774,000 | -13.2% | 50,700 | +58.4% | 0.05% | -41.7% |
| Q2 2017 | $892,000 | +82.0% | 32,000 | +107.8% | 0.08% | +64.7% |
| Q3 2016 | $490,000 | -17.2% | 15,400 | -35.1% | 0.05% | -48.0% |
| Q4 2013 | $592,000 | -6.3% | 23,720 | +3.0% | 0.10% | -3.9% |
| Q3 2013 | $632,000 | -40.0% | 23,020 | -60.3% | 0.10% | -54.9% |
| Q2 2013 | $1,053,000 | – | 58,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |